Kapil Cotex Limited (BSE:512036) agreed to acquire 72.51% stake in Skybiotech Lifesciences Private Limited on April 29, 2024. Skybiotech Lifesciences Private Limited reported the unaudited revenue of approximately INR 110 million for the year 2023-2024. Board of directors of Kapil Cotex Limited (BSE:512036) approved the deal.

The deal is expected to be completed in 30 days.